Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by gottahunchon Oct 05, 2020 11:41am
280 Views
Post# 31666806

PT Raised to $15.50 Cantor Fitzgerald

PT Raised to $15.50 Cantor FitzgeraldAnother user sent me this.
https://thefly.com/landingPageNews.php?id=3169856&headline=APHA-Aphria-price-target-raised-to-C-from-C-at-Cantor-Fitzgerald

Aphria price target raised to C$15.50 from C$12.50 at Cantor Fitzgerald Cantor Fitzgerald analyst Pablo Zuanic raised the firm's price target on Aphria (APHA) to C$15.50 from C$12.50 and keeps an Overweight rating on the shares. Zuanic expects the August/September quarter in Canada to show market growth acceleration sequentially, with companies like Aphria and Canopy Growth (CGC) beating expectations. The analyst sees a buying opportunity with Aphria's recent underperformance, but thinks shares will rally when it reports August quarter results the week of October 12.

Read more at:
https://thefly.com/n.php?id=3169856
<< Previous
Bullboard Posts
Next >>